ArticlePharmacoEconomics - open2019

Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).

Osvaldo Ulises Garay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.